Tonix Pharmaceuticals is enrolling participants in a Phase 3 trial for fibromyalgia, the RALLY study.
For more information, please visit www.RALLYStudy.com or www.clinicaltrials.gov (NCT04508621).
- Home
- Investors
- SEC Filings
- Annual Reports
Annual Reports
| Date | Form | Description | Docs | XBRL | Pages |
| 03/15/21 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
166 |
| 03/24/20 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
173 |
| 03/18/19 | 10-K/A | Annual report pursuant to Section 13 and 15(d) |
|
|
8 |
| 03/18/19 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
154 | |
| 03/09/18 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
130 |
| 09/01/17 | 10-K/A | Annual report pursuant to Section 13 and 15(d) |
|
24 | |
| 04/13/17 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
88 |
| 03/31/17 | NT 10-K | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT |
|
6 | |
| 04/28/16 | 10-K/A | Annual report pursuant to Section 13 and 15(d) |
|
8 | |
| 03/03/16 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
97 |
